Cited by 70Breast Cancer Treatment StudiesBreast Lesions and CarcinomasBreast Implant and Reconstruction

Effect of surgery type on time to adjuvant chemotherapy and impact of delay on breast cancer survival: a national cancer database analysis

Kupstas, Amanda R., Hoskin, Tanya L., Day, Courtney N., Habermann, Elizabeth B., Boughey, Judy C.·2019·Annals of Surgical Oncology

Abstract

Background Timeliness of care is emerging as a quality indicator for breast cancer care. We sought to evaluate the impact of surgical treatment type on time to adjuvant chemotherapy and impact of treatment delay on survival.Methods Patients with stage I-III breast cancer treated with both surgery and adjuvant chemotherapy from 2010 to 2014 were identified from the National Cancer Database (NCDB). Delay in treatment was defined as > 120 days from diagnosis to chemotherapy. Multivariable analysis was performed to assess factors associated with delay in treatment and the effect of treatment delay on overall survival.Results Of 172,043 patients identified, 89.5% initiated chemotherapy within 120 days of diagnosis. Median time from diagnosis to surgery was shorter in patients undergoing breast conservation (25 days) than mastectomy (29 days, p < 0.001) and within mastectomy patients was shorter for mastectomy without reconstruction (26 versus 35 days, p < 0.001). Time from diagnosis to surgery showed larger differences between surgical groups than time from surgery to chemotherapy. On multivariable analysis of mastectomy patients, reconstruction remained significantly associated with delay to chemotherapy [odds ratio (OR) 1.7, p < 0.001]. For all patients regardless of type of surgery, after adjusting for patient, clinical, and treatment factors, delay of > 120 days from diagnosis to chemotherapy was associated with worse overall survival [hazard ratio (HR) 1.29, p < 0.001].Conclusions Initiation of chemotherapy greater than 120 days after diagnosis was associated with poorer overall survival. Time interval from diagnosis to surgery had the greatest impact on time from diagnosis to chemotherapy, with reconstruction resulting in the greatest delay.

Integrity signals

Registry

Crossref · 10.1245/s10434-019-07566-7

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kupstas, A. R., Hoskin, T. L., Day, C. N., Habermann, E. B., & Boughey, J. C.
Affiliations
Mayo Clinic (US)
Corresponding author
Boughey, Judy C.
Venue
Annals of Surgical Oncology
Published
2019-07-22
Volume
26
Issue
10
Pages
3240-3249
ISSN
  • 1068-9265 (ISSN-L)
  • 1534-4681
OpenAlex
W2963166017
Cited by
70
References
21
Citations by year
2026: 5 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 13 · 2019: 2
FWCI
3.31
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Surgical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
  • Health Sciences › Medicine › Surgery › Breast Implant and Reconstruction
Keywords
breast cancer, adjuvant chemotherapy, treatment delay, breast-conserving surgery, mastectomy, breast reconstruction, time to surgery, overall survival, timeliness of care, quality indicators
MeSH terms
Adult, Aged, Aged, 80 and over, Breast Neoplasms, Female, Follow-Up Studies, Humans, Mastectomy, Middle Aged, Prognosis, Retrospective Studies, Time Factors, Survival Rate, Databases, Factual, Chemotherapy, Adjuvant, Time-to-Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review